Study focus: treatment of dementia

Of all the diseases that afflict us, dementia is one of the most terrifying because we see it coming and it is inexorable. It takes the mind but leaves the body. We have theories about what causes Alzheimer’s disease — tangles of a protein called beta-amyloid and over-expression of another protein called tau. These proteins in altered forms were thought to be a cause but removing them from most of the cells in the brain using monoclonal antibodies, did not improve symptoms by much. Perhaps the intervention was too late. Both proteins are probably involved but neither has been a fertile source of treatments, and most clinical trials have failed.

I worked in a Department of Pathology and Cell Biology at Columbia University Irving Medical Center where there are basic scientists and pathologists. A pathologist friend lamented the lack of progress for dementia and Parkinsonism as professionally embarrassing. Heart disease, inflammatory diseases, diabetes, cancer, and other conditions have fared better; there are new and effective treatments to extend life and restore independence, most stemming from basic research in cell biology.

There are many cures offered on the internet, but most are wishful thinking or fraud. One study bears watching: it suggested that vaccination for shingles, a painful rash caused by lingering chickenpox virus (Herpes zoster), reduces the number of cases of dementia in older people. Herpes zoster is a neurotropic virus, that selectively infects nerve cells, whose connections, or synapses in the parts of the brain dedicated to memory are the cellular basis of memory. Each nerve cell has 10,000 or more connections with other neurons.

The study in question hangs on a decision made by the UK’s National Health Service after the Shingrix vaccine became available in 2013. NHS decided to give the vaccine to people in Wales born after Sept. 1, 1933, but not to those born one week before. The two groups, in Wales, 80 years old in 2013, were otherwise identical.Each part of the study had thousands of patients.

The chickenpox vaccine reduced the number of people who became demented over the next 7 years by about 20%. The paper is from scientists at Stanford and several Swiss and German universities. It is tough statistical sledding to read but the data are serious. Twenty percent of patients is too few to be confident, but too many to ignore. See below for the reference.

There are many cures offered on the internet, but most are wishful thinking or fraud.

This experiment has been repeated by combining other data from England and Wales. This type of analysis, involving thousands of patient records, has become possible by keeping records in searchable databases. Other versions of the chickenpox vaccine experiment use a more effective vaccine that became available in 2023. Does the newer vaccine protect better than 20%?Does a vaccine applied when people are younger, or given repeatedly, slow the onset of dementia even better?

Think of a slow acting virus that destroys or inhibits neurons or the synapses involved in memory.It could be Herpes zoster lingering from childhood chickenpox or another virus. The vaccine could induce antibodies and T cells that would stop the progression of the slow virus and stave off dementia.A viral cause of dementia would be extraordinary. And actionable.

A second discovery that may be helpful is the effect of weight loss drugs like Wegovy on dementia. These drugs may also help a number of problems including drug addiction and alcohol abuse.

There are several ways to study the effect of these remarkable drugs. One takes advantage of the fact that loss of brain volume is amarker of Alzheimer’s disease. As the disease progresses damage spreads through the brain and it shrinks, which can be observed by magnetic resonance imaging.

One placebo-controlled trial analyzed 204 patients with mild Alzheimer’s disease at 24 clinics in the United Kingdom. Before the study began, all patients had magnetic resonance imaging of their brains to evaluate structure and volume. Half were given a daily injection of 1.8 milligrams of liraglutide/day, a drug used in weight loss and diabetes, while an equal number received a placebo.Those who received liraglutide lost less brain volume (about 50%) than untreated patients. Cognitive testing was done at 0, 24, and 52 weeks and researchers found that patients who received liraglutide hada slower decline in cognitive function — halfthat of untreated patients. They also said they felt better.

Like the Herpes zoster study the results are not conclusive but at this stage we are looking for a new approach, not miracles. Liraglutide and other GLP-1 analogues are licensed for obesity and diabetes, so its path to treatment for Alzheimer’sand other dementias could be relatively swift.

Two independent and larger phase 3 trials are underway, with results due at the end of 2025. If the results are correct, oneprediction would be that people who had been on weight loss drugs should not be entering memory care units. That analysis is difficult, and some of the databases are proprietary, but we will follow these experiments.


To join a study, go to clinicaltrials.gov. Use the search function.


A natural experiment on the effect of herpes zoster vaccination on dementia

https://doi.org/10.1038/s41586-025-08800-x


Dementia symptoms and areas of the brain

https://www.alzheimers.org.uk/about-dementia/stage...


Evaluation of Novel GLP-1 analogue in the treatment of Alzheimer’s disease

Authors: Paul Edison et al.

Volume: Volume20, IssueS6

DOI: https://doi.org/10.1002/alz.089799

Published: 09 January 2025

PDF: https://alz-journals.onlinelibrary.wiley.com/doi/p....…

Liraglutide is a glucagon-like peptide-1 (GLP-1) analogue licensed for the treatment of type 2 diabetes mellitus (T2DM). Preclinical evidence in transgenic models of Alzheimer’s disease suggests that liraglutide exerts neuroprotective effects by reducing amyloid oligomers.


Richard Kessin, PhD is Emeritus Professor of Pathology and Cell Biology at the Columbia University Irving Medical Center.Richard Kessin, PhD is Emeritus Professor of Pathology and Cell Biology at the Columbia University Irving Medical Center.

The views expressed here are not necessarily those of The Millerton News and The News does not support or oppose candidates for public office.

Latest News

Local Pilates instructor returns home after Miami Dolphins stint

Millbrook resident Jackie Bachor hugs her horse, Dessie, during a tour of her barn and Pilates studio on Tuesday, April 21.

Photo by Graham Corrigan

MILLBROOK — Local Pilates instructor Jackie Bachor has led a career that has taken her from rural upstate New York to Miami and back again — where she is forging a new path that blends her passions for fitness and equestrianism.

Now standing in the sun-drenched studio space of True Pilates Millbrook, Bachor has found space for both. The studio doubles as a stable loft, looking down on Bachor’s horses Dessie and Sammy. When Bachor points around the space to identify Pilates equipment, it’s as if she’s naming horses. At the center of the room is the Cadillac, a raised bed with overhead bars. To the side sits the Barrel, an arced apparatus designed for optimal spinal mobility.

Keep ReadingShow less
Thai tea shop to open in former Candy-O’s space on Main Street

Kanchisar Jaradhanaiphat, left, and John Schildbach hope to open Muanjai Tea on Main Street in Millerton by June 6.

Photo by Nathan Miller

MILLERTON — The former home of Candy-O’s on Main Street will soon get new life, with a Bangkok-inspired tea shop expected to open in June.

Millerton residents John Schildbach and Kanchisar Jiradhanaiphat hope to open Muanjai Tea on June 6. The couple — who are set to be married in May — are currently securing permits to renovate the former candy store, with plans to transform the space into a Thai-inspired tea shop modeled after urban cafés, featuring an elevated atmosphere and menu.

Keep ReadingShow less
Oblong Books placed on NYS Historic Registry

New York State Senator Michelle Hinchey buys two books from Oblong Books in Millerton on Thursday, April 23, after inducting the business into the state Historic Business Preservation Registry.

Photo by Graham Corrigan

MILLERTON — Fifty-one years after Dick Hermans and Holly Nelson opened Oblong Books, the Millerton bookstore has been recognized as part of New York State history.

Following a nomination from state Sen. Michelle Hinchey, Oblong Books was added to the New York State Historic Business Preservation Registry. Hermans and his daughter and co-owner, Suzanna Hermans, celebrated the designation Thursday alongside Hinchey, North East Town Supervisor Christopher Kennan and Kathy Moser, acting commissioner of the New York State Office of Parks, Recreation and Historic Preservation.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

Amenia's Arbor Day celebration

Amenia's Arbor Day celebration
Nathan Miller

A group of gardeners and community members hear Maryanne Snow-Pitts explain proper care for newly-planted tree saplings near the Harlem Valley Rail Trail in Wassaic after Snow-Pitts planted two serviceberry trees in celebration of Arbor Day on Friday, April 24.

Workforce housing subdivision awaits fire company approval
Amenia Town Hall on Route 22.
Photo by Nathan Miller

AMENIA — The proposed workforce housing subdivision on Route 22 is awaiting feedback from the Amenia Fire Company after developers added more water tanks to plans for the property.

Planning Board members discussed other outstanding questions involving the Cascade Creek workforce housing subdivision at their regular meeting on Wednesday, April 22, continuing a conservation subdivision process that began nearly a year ago.

Keep ReadingShow less
‘Vulnerable Earth’ opens at the Tremaine Gallery

Tremaine Gallery exhibit ‘Vulnerable Earth’ explores climate change in the High Arctic.

Photo by Greg Lock

“Vulnerable Earth,” on view through June 14 at the Tremaine Gallery at Hotchkiss, brings together artists who have traveled to one of the most remote regions on Earth and returned with work shaped by first-hand experience of a fragile, rapidly shifting planet, inviting viewers to sit with the tension between awe and loss, beauty and vulnerability.

Curated by Greg Lock, director of the Photography, Film and Related Media program at The Hotchkiss School, the exhibition centers on participants in The Arctic Circle, an expeditionary residency that sends artists and scientists into the High Arctic aboard a research vessel twice a year. The result is a show documenting their lived experience and what it means to stand in a place where climate change is not theoretical but visible, immediate and accelerating.

Keep ReadingShow less
google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.

google preferred source

Want more of our stories on Google? Click here to make us a Preferred Source.